# Low-dose Gonal-f® in Ovulation Induction

> **NCT01871532** · PHASE4 · TERMINATED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 24 (actual)

## Conditions studied

- Infertility
- Monofollicular Development

## Interventions

- **DRUG:** Gonal-f®

## Key facts

- **NCT ID:** NCT01871532
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2014-03
- **Final completion:** 2014-11
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Study was terminated because of delays in sourcing replacement Investigational Medicinal Product for the study due to manufacturing delays.
- **Last updated:** 2016-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01871532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01871532, "Low-dose Gonal-f® in Ovulation Induction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01871532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*